BioAmber Inc (fka BIOAQ)

[TenKay]

"This is a Section 363 sale

There is a asset sale and a stock sale"

Two problems with that.

1) 363 does not apply to the stock of the parent company (in this case BioAmber Inc. and its publicly traded stock). It only applies to the stock of wholly owned subsidiaries in the rare cases the stock of the subsidiary is bought AS PART of the asset sale. That stock is treated as an ASSET of the parent company.

2) Putting that aside, once again, NO DEAL, SALE, AGREEMENT or OFFER TO PURCHASE BIOAQ stock can happen WITHOUT the required public disclosure VIA SEC filings.